1-8 of 8
dosage forms
Close
Sort by
Journal Articles

Sucrosomial Iron ® : A New Highly Bioavaible Oral Iron Supplement

Germano Tarantino, MD, Elisa Brilli, PhD, Ylenia Zambito, PhD, Giulio Giordano, MD, Francesco Equitani, MD
Journal: Blood
Blood (2015) 126 (23): 4561.
https://doi.org/10.1182/blood.V126.23.4561.4561
Published: 2015
Journal Articles

HLA-DRB1*07:01 Is Associated With Asparaginase Allergies In Children With Acute Lymphoblastic Leukemia

Christian A Fernandez, PhD, Mary V. Relling, PharmD, Colton Smith, PhD, Wenjian Yang, PhD, Eric C. Larsen, MD, W. Paul Bowman, MD, Chengcheng Liu, Laura B. Ramsey, PhD, Tamara Chang, MD, Victoria Turner, PhD, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Naomi J. Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD, Suna Onengut-Gumuscu, PhD, Wei-Min Chen, PhD, Patrick Concannon, PhD, Stephen S Rich, PhD, Paul Scheet, PhD, Sima Jeha, MD, Ching-Hon Pui, MD, William E. Evans, PharmD, Meenakshi Devidas, PhD
Journal: Blood
Blood (2013) 122 (21): 60.
https://doi.org/10.1182/blood.V122.21.60.60
Published: 2013
Journal Articles

L-Asparaginase Loaded Red Blood Cells: From Prescription to Injection

Jerome Bailly, Pharm.D, Veronique Sezanne, Pharm.D, Yann Godfrin, PhD
Journal: Blood
Blood (2011) 118 (21): 4252.
https://doi.org/10.1182/blood.V118.21.4252.4252
Published: 2011
Journal Articles

A Phase 1 Trial of Oral Ponatinib (AP24534) In Patients with Refractory Chronic Myelogenous Leukemia (CML) and Other Hematologic Malignancies: Emerging Safety and Clinical Response Findings

Jorge Cortes, MD, Moshe Talpaz, MD, Dale Bixby, Michael Deininger, MD, PhD, Neil Shah, MD, PhD, Ian W. Flinn, MD, PhD, Michael Mauro, MD, Thomas O'Hare, PhD, Simin Hu, PhD, Rebecca Kan, Victor M. Rivera, PhD, Tim Clackson, PhD, Frank Haluska, MD, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 210.
https://doi.org/10.1182/blood.V116.21.210.210
Published: 2010
Journal Articles

Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects.

Shaker A. Mousa, PhD, Haifeng Zhang, PhD, Ahmad Aljada, PhD, Fuming Zhang, PhD, Ehud Arbit, MD, Lewis Bender, PhD, Michael Goldberg, MD, Robert Linhardt, PhD
Journal: Blood
Blood (2007) 110 (11): 4009.
https://doi.org/10.1182/blood.V110.11.4009.4009
Published: 2007
Journal Articles

Development of an Oral Dosage Form of Azacitidine: Overcoming Challenges in Chemistry, Formulation, and Bioavailability.

Maxine L. Stoltz, PhD, Jeffrey B. Etter, PhD, Tanja Obradovic, PhD, Richard Jia, MS
Journal: Blood
Blood (2006) 108 (11): 4850.
https://doi.org/10.1182/blood.V108.11.4850.4850
Published: 2006
Journal Articles

Oral Bioavailability of Mycophenolate Mofetil in Patients Undergoing Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Is Poor and Highly Variable.

Pamala Jacobson, PharmD, Green Kathleen, PharmD, John Rogosheske, PharmD, Claudio Brunstein, MD, Juliet Barker, MBBS, Todd DeFor, MS, Philip McGlave, MD, Daniel Weisdorf, MD
Journal: Blood
Blood (2005) 106 (11): 842.
https://doi.org/10.1182/blood.V106.11.842.842
Published: 2005
Journal Articles

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Alessandro Gringeri, MD, MSc, Piermannuccio Mannucci, MD, Mara Monzini, PharmD, Luciana Scalone, PharmD, Lorenzo Mantovani, MSc, DSc
Journal: Blood
Blood (2004) 104 (11): 2203.
https://doi.org/10.1182/blood.V104.11.2203.2203
Published: 2004